Stealth and pseudo-stealth nanocarriers

Area of Science:

• Materials Science
• Nanotechnology
• Pharmacology

Background:

• The stealth effect is crucial for nanomaterial drug delivery, enhancing pharmacokinetics like blood circulation and tissue targeting.
• Current stealth strategies often involve polymer-based stabilization (e.g., PEGylation) or bio-inspired components to evade immune detection.

Purpose of the Study:

• To provide an integrated material and biological perspective on engineering stealth nanomaterials.
• To analyze stealth efficiency and discuss factors influencing it.
• To propose strategies for improving nanomaterial pharmacokinetics.

Main Methods:

• Practical analysis of stealth efficiency in reported nanomaterials.
• Theoretical discussion of factors affecting stealth properties.
• Evaluation of pharmacokinetic data, including blood concentration and clearance rates.

Main Results:

• Over 85% of reported stealth nanomaterials exhibit a rapid decline in blood concentration (half-life within 1 hour).
• This behavior is termed the pseudo-stealth effect, characterized by dose-dependent, nonlinear pharmacokinetics due to saturated reticuloendothelial system (RES) clearance.
• Structural holism, considering the entire surface structure and geometry, is proposed as a superior approach over single-factor strategies.

Conclusions:

• Minimizing attractive binding sites through engineered structural hierarchies (minimal charges, dipoles, hydrophobic domains) is crucial for enhanced stealth.
• The pseudo-stealth effect highlights the need for advanced strategies beyond traditional PEGylation.
• Future development should focus on the pragmatic implementation of the pseudo-stealth effect and dynamic modulation of stealth properties.